Immunome Inc. Operating Margin in % from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Immunome Inc. quarterly/annual Operating Margin history and growth rate from 2023 to Q3 2025.
  • Immunome Inc. Operating Margin for the quarter ending September 30, 2025 was -2.42K %, a 22.8% increase year-over-year.
  • Immunome Inc. annual Operating Margin for 2024 was -3.38K %, a 333% decline from 2023.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Immunome Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -2.42K +715 +22.8% Jul 1, 2025 Sep 30, 2025
Q2 2025 -1.78K +734 +29.2% Apr 1, 2025 Jun 30, 2025
Q1 2025 -1.99K -123 -6.56% Jan 1, 2025 Mar 31, 2025
Q4 2024 -3.38K -2.6K -333% Oct 1, 2024 Dec 31, 2024
Q3 2024 -3.13K Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.52K Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.87K Jan 1, 2024 Mar 31, 2024
Q4 2023 -781 Oct 1, 2023 Dec 31, 2023

Immunome Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -3.38K -2.6K -333% Jan 1, 2024 Dec 31, 2024
2023 -781 Jan 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.